Finance: Page 116

FSD Pharma Achieves Over 4 Billion Shares Traded in First 6 Months

The company has traded over four billion Class B subordinate voting shares in its first six months of trading on the Canadian Securities Exchange.

Robert Sampson Announces Holdings in Cresco Labs Inc.

Sampson holds and controls his shares of the company for investment purposes only.

Canopy Growth and Canopy Rivers Announce Completion of TerrAscend Restructuring

The companies have announced the closing of the previously announced restructuring transaction with TerrAscend Corp.

Tax Court Reinforces IRS Code 280E in Harborside Ruling

Cannabis dispensaries are no different than drug traffickers in the eyes of the IRS, according to U.S. Tax Court.

Utah Banks, Credit Unions Wary of Medical Marijuana Money

A Utah banking industry representative said the funds cannot go to banks, even when the state says medical marijuana is legal.

Michigan's Marijuana Tax Revenue Would Be Gutted by Lame Duck Bill

A bill proposed by outgoing Senate Majority Leader Arlan Meekhof would significantly change the voter-approved recreational marijuana program in Michigan.

Credit Union to Work With Alaska Marijuana Business in Pilot Program

That pilot program will offer services to marijuana businesses that include accounts, deposits and withdraws, and eventually hope to set up payroll operations.

Lift & Co. Announces Winners of 2018 Canadian Cannabis Awards

CannTrust won Licensed Producer of the Year.

Sproutly Adds Former Pernod Ricard Beverage Executive to Advisory Board

Constantine Constandis is a former senior executive with wine and spirits producer Pernod Ricard, and has over 34 years of experience in the wine and spirits industry.

Ailing U.S. Farmers Covet New Cash Bonanza From Hemp

Congress is on the verge of fully legalizing hemp under a new farm bill.

Dixie Brands Inc. Completes Reverse Takeover Transaction

As part of the reverse takeover, Academy changed its name to Dixie Brands Inc,, and its officers and directors have resigned.

FSD Pharma Facility Valued at $105 Million With Three-Million-Foot Expansion Assessed at $420 Million

The value is based on a recent Comprehensive Property Value Assessment by a commercial real estate assessment specialist.

Previous Page

Page 116 of 184

Next Page